Results 171 to 180 of about 27,665 (215)

PEPRVision: a visualization framework for Pharmacoepidemiology research. [PDF]

Am J Epidemiol
Wang Y, Chen HK, Wen W, Cole DV, Maro JC, Rosales AN, Rasmussen SA, Winterstein AG.   +7 more
europepmc   +1 more source

Comparative performance of large language models for appraising bias in real-world evidence studies. [PDF]

J Manag Care Spec Pharm
Okeke CM, Nechi R, Khalid J, Karaye IM, Thornton JD, Yunusa I.   +5 more
europepmc   +1 more source

Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Mexico: a systematic review. [PDF]

J Comp Eff Res
Ceballos Ruiz C, Navarro A.
europepmc   +1 more source

Correction: Impact of COVID-19 lockdown on methadone and buprenorphine prescriptions in England primary cares: an interrupted time series analysis. [PDF]

Harm Reduct J
Chang YC, Liao WC, Chen LC, Chen TC.
europepmc   +1 more source

Correction to "Demystifying Clone-Censor-Weighting to Studying Treatment Initiation Windows: An Example Using Publicly Available Synthetic Medicare Claims Data". [PDF]

Pharmacoepidemiol Drug Saf
europepmc   +1 more source

A Hierarchical Risk Assessment Framework for Population-Specific Statin Safety Labelling. [PDF]

Pharmacoepidemiol Drug Saf
Tsui L.
europepmc   +1 more source

Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies. [PDF]

Paediatr Perinat Epidemiol
Nohmie G, Bérard A, Pottegård A, Bliddal M.   +3 more
europepmc   +1 more source

What aging research loses between data and meaning: Representational flattening. [PDF]

JAR Life
Khachaturian AS.
europepmc   +1 more source